Hypertrophic cardiomyopathy (HCM) affects about 1 in 500 people in the United States, making it a relatively common genetic heart condition1 . This disease causes thickening of the heart muscle, especially the left ventricle, which can reduce the heart's ability to pump blood effectively2 . While many people with HCM live normal lives without symptoms, some experience serious complications such as chest pain, arrhythmias, and sudden cardiac death3 . Early diagnosis and proper management are essential to improve outcomes and quality of life4 .
Hypertrophic Cardiomyopathy Symptoms
Hypertrophic cardiomyopathy symptoms vary widely among individuals, with many patients remaining asymptomatic, especially in the early stages of the disease5 . Common symptoms include chest pain during physical exertion, which occurs due to the thickened heart muscle requiring more oxygen than the blood supply can provide5 . Patients often experience arrhythmias—abnormal heart rhythms—that can increase the risk of sudden cardiac death5 . In advanced cases, signs of heart failure such as peripheral edema (swelling in the lower limbs) may develop5 .
Other symptoms frequently reported include shortness of breath during exercise, fatigue, dizziness, palpitations, and fainting episodes, particularly during or after exertion6 . These symptoms result from the heart's impaired ability to pump blood efficiently due to muscle thickening and possible obstruction of blood flow1 .
The New York Heart Association (NYHA) functional classification is commonly used to assess symptom severity and guide treatment decisions in patients with HCM7 .
- Many patients with HCM remain asymptomatic, especially early in the disease5
- Chest pain during exertion is a common symptom in patients with hypertrophic cardiomyopathy5
- Patients with HCM often experience arrhythmias, which can increase the risk of sudden cardiac death5
- Peripheral edema is a sign of advanced heart failure in hypertrophic cardiomyopathy5
Nearly 30% of patients with hypertrophic cardiomyopathy experience sudden cardiac death as their very first symptom. This condition often affects seemingly healthy young adults and athletes, underscoring the importance of early detection3 .
Causes of Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy is primarily caused by genetic mutations affecting the heart muscle's contractile proteins. More than 1,400 mutations in at least 11 genes encoding cardiac sarcomere proteins have been linked to HCM8 . The most commonly affected genes are MYH7 and MYBPC3, which code for beta-myosin heavy chain and myosin-binding protein C, respectively9 10.
HCM is inherited in an autosomal dominant pattern, meaning a person has a 50% chance of inheriting the mutation if one parent carries it10 . However, the disease shows variable penetrance, so not all individuals with the mutation develop symptoms or significant heart muscle thickening10 . Mutations disrupt the normal function of sarcomeric proteins, which are essential for myocardial contraction and relaxation, leading to abnormal heart muscle growth and stiffness10 .
Genetic heterogeneity contributes to the wide range of clinical presentations and prognosis seen in HCM patients10 . Genetic testing is increasingly used to confirm diagnosis and guide family screening, allowing early identification of at-risk relatives9 .
- HCM is primarily inherited in an autosomal dominant manner, with variable penetrance10
- Mutations in sarcomeric protein genes are the main cause of hypertrophic cardiomyopathy10
- Sarcomeric proteins are essential for myocardial contraction and relaxation, and their mutations disrupt normal heart muscle function10
- Genetic heterogeneity in HCM affects clinical presentation and prognosis10
- Genetic testing helps confirm diagnosis and guide family screening9
Hypertrophic cardiomyopathy (HCM) is an autosomal dominant cardiac myocyte disease caused by mutations in sarcomere protein genes encoding elements of the contractile machinery of the heart11 .
Diagnosing Hypertrophic Cardiomyopathy
Diagnosis of hypertrophic cardiomyopathy involves a combination of clinical evaluation, imaging, and genetic testing. Early clinical evaluation is recommended for individuals with suspected HCM or a positive family history12 . A detailed clinical history and physical examination help identify symptoms and risk factors12 .
The primary diagnostic tool is echocardiography, which visualizes the thickened left ventricular wall and assesses the degree of hypertrophy12 . Diagnostic criteria in adults include a maximal end-diastolic wall thickness of 15 mm or more in one or more segments of the left ventricle, without other causes such as hypertension13 14. In family members or genotype-positive individuals without clear hypertrophy, a wall thickness of 13-14 mm can be diagnostic14 .
Electrocardiogram (ECG) abnormalities are common in HCM and may show signs of left ventricular hypertrophy or arrhythmias12 . Holter monitoring is used to detect intermittent arrhythmias, while exercise stress testing assesses functional capacity and provokes symptoms12 . Cardiac magnetic resonance imaging (MRI) provides detailed myocardial tissue characterization and can detect fibrosis, which is important for risk stratification15 . Cardiac catheterization and electrophysiological studies may be performed in selected patients to evaluate outflow tract obstruction and arrhythmia risk13 .
- Early clinical evaluation is recommended for individuals with suspected HCM or positive family history12
- Diagnostic workup includes ECG, echocardiography, Holter monitoring, and stress testing12
- Echocardiography is the primary imaging modality for diagnosing HCM and assessing left ventricular hypertrophy12
- Cardiac MRI detects fibrosis and aids in risk stratification15
- Genetic testing is performed in patients with clear phenotypic evidence to guide family screening14
Hypertrophic cardiomyopathy (HCM) is characterized by left ventricular hypertrophy in the absence of another cardiac, systemic, or metabolic disease. Clinical diagnosis in adults is established by imaging showing maximal end-diastolic wall thickness ≥15 mm anywhere in the left ventricle14 .
Hypertrophic Cardiomyopathy Treatment Options
Treatment of hypertrophic cardiomyopathy aims to relieve symptoms, prevent sudden cardiac death, and improve quality of life5 . Many patients respond well to medical therapy, while others may require invasive procedures.
Medications commonly used include beta-blockers and calcium channel blockers, which reduce heart rate and improve diastolic filling5 . Disopyramide, an antiarrhythmic drug with negative inotropic effects, is used in obstructive HCM to reduce outflow tract obstruction7 5. Newer agents like mavacamten, a myosin inhibitor, show promise in managing obstructive HCM but require specialist oversight16 .
For patients with refractory symptoms and significant left ventricular outflow tract obstruction, invasive septal reduction therapies are effective. Septal myectomy is an open-heart surgery that removes excess thickened muscle to relieve obstruction17 . Alcohol septal ablation involves injecting alcohol into a septal artery to induce a controlled myocardial infarction, reducing the thickened muscle18 17.
Implantable cardioverter-defibrillators (ICDs) are recommended for patients at high risk of sudden cardiac death, such as those with a history of arrhythmias or family history of sudden death5 . Pacemakers may be used in select cases with conduction abnormalities19 .
- Beta-blockers, calcium channel blockers, and disopyramide manage symptoms and reduce obstruction5
- Septal myectomy surgery removes excess muscle in obstructive HCM17
- Alcohol septal ablation is a less invasive alternative to surgery18 17
- Implantable cardioverter-defibrillators prevent sudden cardiac death in high-risk patients5
- Antiarrhythmic drugs and anticoagulation are used in selected patients5
Hypertrophic cardiomyopathy is treatable when detected early, and most patients can live long, healthy lives with proper care4 .
| Treatment Option | Purpose | Notes |
|---|---|---|
| Beta-blockers | Reduce heart rate, improve filling | First-line medical therapy5 |
| Calcium channel blockers | Improve diastolic function | Alternative or adjunct5 |
| Disopyramide | Reduce outflow obstruction | Used in obstructive HCM7 |
| Septal myectomy | Surgical removal of thickened muscle | For refractory obstruction17 |
| Alcohol septal ablation | Percutaneous reduction of septal thickness | Less invasive alternative18 17 |
| Implantable defibrillator | Prevent sudden cardiac death | For high-risk patients5 |
| Sources: 5717 | ||
Preventing Hypertrophic Cardiomyopathy Complications
Preventing complications in hypertrophic cardiomyopathy focuses on managing symptoms, reducing the risk of sudden cardiac death, and improving heart function5 . Risk stratification involves assessing family history, presence of arrhythmias, syncope episodes, and the extent of hypertrophy20 .
Lifestyle modifications include individualized exercise recommendations, generally encouraging moderate activity while avoiding vigorous or competitive sports that increase sudden death risk5 21. Medical adherence is crucial to control symptoms and prevent progression22 .
Invasive therapies such as septal myectomy and alcohol septal ablation are reserved for patients with obstructive HCM who remain symptomatic despite optimal medical therapy7 5. Implantable cardioverter-defibrillators are essential for sudden death prevention in high-risk individuals5 .
- Treatment aims to alleviate symptoms, prevent sudden cardiac death, and improve quality of life5
- Exercise recommendations should be individualized, with caution regarding vigorous activity5
- Beta-blockers and calcium channel blockers help manage symptoms and reduce obstruction5
- Invasive therapies are effective for refractory obstructive HCM5
- ICDs are used for sudden death prevention in high-risk patients5
Hypertrophic cardiomyopathy is a leading cause of sudden cardiac death in young athletes. Careful risk assessment and preventive measures can save lives5 .
Living With Hypertrophic Cardiomyopathy
Living with hypertrophic cardiomyopathy requires ongoing medical care, lifestyle adjustments, and family support. Genetic counseling is recommended for affected families to understand inheritance patterns and guide screening of relatives22 . Regular clinical surveillance is essential to monitor disease progression and adjust treatment22 .
Patients are encouraged to engage in regular moderate exercise, which supports cardiovascular health, but intense physical activity may be contraindicated due to risk of arrhythmias and sudden death23 . A balanced diet and stress management can also improve overall well-being22 . Adherence to prescribed medications is vital for symptom control and prevention of complications22 .
- Genetic counseling helps families understand inheritance and screening22
- Ongoing clinical surveillance is essential for patients and at-risk relatives22
- Moderate exercise is beneficial; intense exercise may be harmful23
- Balanced diet supports cardiovascular health22
- Adherence to medical therapy improves outcomes22
Hypertrophic cardiomyopathy is most often inherited and results from defects in genes that control heart muscle growth6 .
Frequently Asked Questions
Can people with hypertrophic cardiomyopathy live a normal life?
Yes, many patients with HCM have a normal life expectancy with appropriate management and regular follow-up care22 .
What are the main risks associated with HCM?
HCM carries risks of heart failure and sudden cardiac death, although these are uncommon with modern treatments and careful monitoring22 .
How is sudden cardiac death risk assessed in HCM?
Risk stratification involves evaluating family history, arrhythmias, syncope, and the degree of heart muscle thickening20 . High-risk patients may receive implantable defibrillators to prevent sudden death5 .
Is hypertrophic cardiomyopathy inherited?
Yes, HCM is usually inherited in an autosomal dominant pattern, meaning family members may also be at risk and should undergo screening22 .
What lifestyle changes are recommended for HCM patients?
Patients should avoid vigorous or competitive sports, maintain moderate exercise, follow a heart-healthy diet, and adhere to medical therapy22 5.
